Business
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
Oxford, UK – 8 May 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT), taking place from 11-15 May in Boston. OXB will exhibit at Booth #1331, where its commercial team will be available to discuss how OXB supports the development and manufacture of cell and gene therapies from pre-clinical through to commercialisation. Representing OXB onsite w
About this update from Oxford Biomedica Plc
[{"type":"image","alt":"OXB","displaySize":"","headline":null,"caption":"OXB","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":159,"url":"https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_G2HBSBQK2zJ4HuhalS08Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMw--/https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2","width":300,"height":159},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/_G2HBSBQK2zJ4HuhalS08Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMw--/https://media.zenfs.com/en/globenewswire.com/c14d9d68668513a9042681f5e1f388c2","width":300,"height":159}},"lazy":false},{"type":"text","content":"Oxford, UK – 8 May 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT), taking place from 11-15 May in Boston.","length":262,"tagName":"p"},{"type":"text","content":"OXB will exhibit at Booth #1331, where its commercial team will be available to discuss how OXB supports the development and manufacture of cell and gene therapies from pre-clinical through to commercialisation. Representing OXB onsite will be Sébastien Ribault, PhD, Chief Business Officer, alongside Business Development Directors Mark Marrano, Lisa Parenteau, and Shyamali Mandal, PhD.","length":388,"tagName":"p"},{"type":"text","content":"In addition, OXB will contribute to the conference’s scientific program through a workshop, an industry symposium, three oral presentations, and seven poster presentations spanning automation in CGT manufacturing, AAV and lentivirus process development, and vector manufacturing and innovation.","length":294,"tagName":"p"},{"type":"text","content":"Workshop participation","length":22,"tagName":"p"},{"type":"text","content":"Workshop: Automation in CGT manufacturing: From production to QCSession: Automation of Cell Based Assays-QC Implementation Strategies and ChallengesPresenter: Dr. André Raposo, Senior Director, InnovationDate: Monday 11 MayTime: 16:04-16:34 EDTRoom: 162AB","length":260,"tagName":"p"},{"type":"text","content":"Industry-sponsored symposium","length":28,"tagName":"p"},{"type":"text","content":"Title: Beyond the Buzzword: What ‘Commercial-Ready’ Really Means in Cell...